Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration - Additional information regarding baseline lesion composition's impact on vision outcomes - TAP report No. 3

To explore how baseline lesion composition influenced vision outcomes in patients with age-related macular degeneration (AMD) undergoing photodynamic therapy with verteporfin (Visudyne) for subfoveal choroidal neovascularization (CNV) in the Treatment of Age-Related Macular Degeneration With Photodynamic Therapy Investigation.


Published in:
Archives of Ophthalmology, 120, 11, 1443-1454
Year:
2002
Publisher:
American Medical Association
ISSN:
0003-9950
Keywords:
Laboratories:




 Record created 2007-07-20, last modified 2018-03-08


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)